Topaly, J., Zeller, W. J., & Frühauf, S. (2001). Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells. Leukemia, 15(3), . https://doi.org/10.1038/sj.leu.2402041
Chicago-Zitierstil (17. Ausg.)Topaly, Julian, W. Jens Zeller, und Stefan Frühauf. "Synergistic Activity of the New ABL-specific Tyrosine Kinase Inhibitor STI571 and Chemotherapeutic Drugs on BCR-ABL-positive Chronic Myelogenous Leukemia Cells." Leukemia 15, no. 3 (2001). https://doi.org/10.1038/sj.leu.2402041.
MLA-Zitierstil (9. Ausg.)Topaly, Julian, et al. "Synergistic Activity of the New ABL-specific Tyrosine Kinase Inhibitor STI571 and Chemotherapeutic Drugs on BCR-ABL-positive Chronic Myelogenous Leukemia Cells." Leukemia, vol. 15, no. 3, 2001, https://doi.org/10.1038/sj.leu.2402041.